Health News

Still Sharp After Anesthesia
Being a bit foggy in the brain during the weeks or months after major surgery is a reality for many aging adults. But it’s not a certain sign of any lasting problems with their mental health such as dementia or Alzheimer's disease.
Depression and a Declining Mind
Healthcare providers have been searching for ways to reduce the risk for developing dementia. Treating depression may, in some way, help the mind stay sharp.
The Dollars for Dementia Add Up Fast
No one on Earth is getting any younger. And with age comes the higher health costs associated with a range of health conditions. Top among them may be dementia.
Linking Poor Sleep and Alzheimer's
Poor sleep is linked to a wide range of possible ailments. However, it also works the other way around. Poor sleep can also be a sign that illness is contributing to the bad sleep.
Blood Pressure & Signs of a Declining Mind
Maintaining a healthy blood pressure is important for a lot of reasons. For people with a family history of Alzheimer’s disease, it may help prevent early Alzheimer’s symptoms.
Depression Put Alzheimer’s on Fast Track
Depression can make the most on-the-ball people feel like their brains are mush. In people with Alzheimer’s disease, depression may speed up disease symptoms.
Antioxidants for the Brain
Antioxidants - which are found in foods like soy products, coffee and fruits - have been shown to be healthy substances for the body. Researchers wanted to see if they could also lower risk of dementia and stroke.
Should Brain Scans Diagnose Dementia?
Dementia causes changes in the brain. But should brain imaging be used to diagnose Alzheimer’s disease? Experts say that doctors should use imaging cautiously.
How Much do Dementia Treatments Help?
Treatments for dementia target symptoms. Many help improve memory and thinking. But does improving symptoms lead to better quality of life?
FDA Offers New Guidance on Developing Drugs for Alzheimer’s Disease
Today, the US Food and Drug Administration issued a proposal designed to assist companies developing new treatments for patients in the early stages of Alzheimer’s disease, before the onset of noticeable (overt) dementia.